Akebia Ther Correlations

AKBA Stock

USD 2.33 0.03 1.30%

The current 90-days correlation between Akebia Ther and Seres Therapeutics is 0.09 (i.e., Significant diversification). The correlation of Akebia Ther is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Akebia Ther Correlation With Market

Modest diversification

The correlation between Akebia Ther and DJI is 0.23 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Akebia Ther and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akebia Ther. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.

Moving together with Akebia Stock

0.65	BMY	Bristol Myers Squibb Earnings Call This Week	Pair Corr
0.62	GILD	Gilead Sciences Earnings Call This Week	Pair Corr
0.85	BPMC	Blueprint Medicines Corp Sell-off Trend	Pair Corr
0.74	AVAL	Grupo Aval	Pair Corr

Moving against Akebia Stock

0.72	INZY	Inozyme Pharma	Pair Corr
0.65	LPTX	Leap Therapeutics	Pair Corr
0.64	MREO	Mereo BioPharma Group	Pair Corr
0.48	MRK	Merck Company Earnings Call This Week	Pair Corr
0.45	PDSB	PDS Biotechnology Corp	Pair Corr
0.35	NKTX	Nkarta Inc	Pair Corr
0.33	LLY	Eli Lilly Earnings Call This Week	Pair Corr
0.51	TERN	Terns Pharmaceuticals Buyout Trend	Pair Corr
0.5	APTO	Aptose Biosciences	Pair Corr
0.47	PLRX	Pliant Therapeutics	Pair Corr
0.43	ABOS	Acumen Pharmaceuticals	Pair Corr
0.4	AFMD	Affimed NV	Pair Corr
0.32	ADAP	Adaptimmune Therapeutics	Pair Corr
0.43	ACET	Adicet Bio	Pair Corr

Related Correlations Analysis

	PLX	CDTX	XFOR	MCRB	AVRO	CWBR	OCEA	ENVB	ELEV	HEPA
PLX		0.75	0.2	0.43	0.71	0.66	-0.84	-0.64	0.54	-0.74	PLX
CDTX	0.75		0.46	0.64	0.49	0.7	-0.57	-0.57	0.45	-0.38	CDTX
XFOR	0.2	0.46		0.36	0.41	0.24	-0.18	0.1	0.26	-0.24	XFOR
MCRB	0.43	0.64	0.36		0.13	0.65	-0.3	-0.4	0.2	-0.28	MCRB
AVRO	0.71	0.49	0.41	0.13		0.36	-0.55	-0.15	0.4	-0.69	AVRO
CWBR	0.66	0.7	0.24	0.65	0.36		-0.58	-0.56	0.38	-0.5	CWBR
OCEA	-0.84	-0.57	-0.18	-0.3	-0.55	-0.58		0.81	-0.23	0.84	OCEA
ENVB	-0.64	-0.57	0.1	-0.4	-0.15	-0.56	0.81		-0.01	0.5	ENVB
ELEV	0.54	0.45	0.26	0.2	0.4	0.38	-0.23	-0.01		-0.18	ELEV
HEPA	-0.74	-0.38	-0.24	-0.28	-0.69	-0.5	0.84	0.5	-0.18		HEPA
	PLX	CDTX	XFOR	MCRB	AVRO	CWBR	OCEA	ENVB	ELEV	HEPA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

HEPA	+ 0.84	OCEA
ENVB	+ 0.81	OCEA
CDTX	+ 0.75	PLX
AVRO	+ 0.71	PLX
CWBR	+ 0.7	CDTX
CWBR	+ 0.66	PLX

High negative correlations

OCEA	- 0.84	PLX
HEPA	- 0.74	PLX
HEPA	- 0.69	AVRO
ENVB	- 0.64	PLX
OCEA	- 0.58	CWBR
ENVB	- 0.57	CDTX

Risk-Adjusted Indicators

There is a big difference between Akebia Stock performing well and Akebia Ther Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Akebia Ther's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
PLX	3.00	1.38	0.37	(5.38)	2.35	(4.13)	7.61	(4.92)	27.92
CDTX	4.26	0.83	0.15	1.95	4.42	(4.94)	12.90	(8.38)	32.32
XFOR	8.57	1.76	0.11	(1.02)	10.68	(12.10)	32.50	(13.51)	67.48
MCRB	4.65	0.19	0.04	0.22	4.21	(7.27)	15.58	(6.78)	28.84
AVRO	1.77	0.13	0.03	0.69	1.89	(2.24)	4.11	(3.17)	14.20
CWBR	7.34	2.62	0.33	(1.15)	5.34	(11.19)	5.73	(5.59)	250.97
OCEA	4.60	(1.84)	0.00	11.33	0.00	0.00	7.46	(9.46)	42.78
ENVB	3.65	(0.78)	0.00	0.99	0.00	0.00	9.78	(8.05)	36.97
ELEV	5.00	0.19	0.03	0.30	5.40	(6.16)	10.77	(8.62)	40.61
HEPA	6.86	(1.09)	0.00	(7.92)	0.00	0.00	12.31	(10.53)	86.86

Akebia Ther Corporate Management

Nicole Hadas	Sr. VP, General Counsel and Secretary	Profile
Kristie Bolieau	VP Controller	Profile
Mercedes Carrasco	Director Communications	Profile
David Spellman	CFO VP	Profile
Tracey Vetterick	Vice Administration	Profile
Thierry Bilbault	VP Devel	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC